Skip to search.
 BSE Up 1.17% NSE Up 1.38%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.30 Up 0.01(3.45%) 9:41PM - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.29
Open:0.30
Bid:0.30 x 1100
Ask:0.30 x 5500
1y Target Est:1.43
Beta:2.06
Next Earnings Date:N/A
Day's Range:0.29 - 0.31
52wk Range:0.26 - 1.54
Volume:1,967,075
Avg Vol (3m):3,314,320
Market Cap:28.77M
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for AEZS at this time.

Comparison

Symbol% ChgMkt Cap
AEZSUp 3.45%28.77M
CELGUp 0.13%91.28B
ENMDUp 1.79%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):331.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback